ArticleDrug design, development and therapy2019

A Novel Nanomicellar Combination of Fenretinide and Lenalidomide Shows Marked Antitumor Activity in a Neuroblastoma Xenograft Model.

Isabella Orienti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.